Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001325812-15-000021
Filing Date
2015-03-03
Accepted
2015-03-03 18:48:44
Documents
1
Period of Report
2015-02-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5365
  Complete submission text file 0001325812-15-000021.txt   7004
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 801 INSPIRATION LANE GAITHERSBURG MD 20878
Business Address
Price Ben Gil (Reporting) CIK: 0001417915 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14895 | Film No.: 15671196